Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2024 Filed Jun 17, 2024 20:49 UTC |
Barr EliavDirector
|
GrantCommon Stock | 11,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000104 · wk-form4_1718657334.xml · nonDerivative · entry 1 Barr Eliav · CIK 0001940521 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,868 F1 · kind: Restricted stock units awarded on June 13, 2024 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 20:48 UTC |
EPSTEIN ROBERT SDirector
|
GrantCommon Stock | 11,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000101 · wk-form4_1718657299.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,598 F1 · kind: Restricted stock units awarded on June 13, 2024 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 20:48 UTC |
EASTHAM KARINDirector
|
GrantCommon Stock | 11,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000100 · wk-form4_1718657288.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,728 F1 · kind: Restricted stock units awarded on June 13, 2024 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 20:48 UTC |
Bhanji MunaDirector
|
GrantCommon Stock | 11,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000102 · wk-form4_1718657310.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,578 F1 · kind: Restricted stock units awarded on June 13, 2024 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:24 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 3,870 | $20.59 | $79,683.30 |
DisclosureSEC source: 0001384101-24-000091 · wk-form4_1718310242.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,255 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 8, 2024. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 20:22 UTC |
Bhanji MunaDirector
|
SaleCommon Stock | 3,870 | $20.32 | $78,633.76 |
DisclosureSEC source: 0001384101-24-000086 · wk-form4_1718137320.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,105 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2024. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $19.97 to $20.88. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:21 UTC |
EASTHAM KARINDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0001384101-24-000085 · wk-form4_1718137309.xml · derivative · entry 3 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 8, 2024. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:21 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 2,500 | $20.97 | $52,425.00 |
DisclosureSEC source: 0001384101-24-000085 · wk-form4_1718137309.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,125 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 8, 2024. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:21 UTC |
EASTHAM KARINDirector
|
Exercise / conversionCommon Stock | 2,500 | $10.41 | $26,025.00 |
DisclosureSEC source: 0001384101-24-000085 · wk-form4_1718137309.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 8, 2024. Read SEC document |
| June 02, 2024 Filed Jun 4, 2024 20:43 UTC |
McGuire AnnieSVP, General Counsel
|
Tax withholdingCommon Stock | 1,919 | $20.75 | $39,819.25 |
DisclosureSEC source: 0001384101-24-000078 · wk-form4_1717533785.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,406 F1 · kind: The reporting person is reporting the withholding of 724, 453 and 742 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,428, 892 and 1,463 Restricted Stock Units granted on February 28, 2022, August 5, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2024 Filed Jun 4, 2024 20:43 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 3,462 | $20.75 | $71,836.50 |
DisclosureSEC source: 0001384101-24-000079 · wk-form4_1717533798.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,240 F1 · kind: The reporting person is reporting the withholding of 1,077, 657, 904 and 824 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,295, 1,783 and 1,625 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2024 Filed Jun 4, 2024 20:42 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,746 | $20.75 | $119,229.50 |
DisclosureSEC source: 0001384101-24-000077 · wk-form4_1717533771.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,994 F1 · kind: The reporting person is reporting the withholding of 1,483, 1,791 and 2,472 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926, 3,533 and 4,877 Restricted Stock Units granted on June 1, 2021, March 3, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2024 Filed Jun 4, 2024 20:42 UTC |
Leite JohnChief Commercial Officer-CLIA
|
Tax withholdingCommon Stock | 1,314 | $20.75 | $27,265.50 |
DisclosureSEC source: 0001384101-24-000076 · wk-form4_1717533757.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,245 F1 · kind: The reporting person is reporting the withholding of 814 and 500 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,606 and 985 Restricted Stock Units, respectively, granted on September 1, 2022 and March 6, 2023 respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2024 Filed Jun 4, 2024 20:42 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,087 | $20.75 | $22,555.25 |
DisclosureSEC source: 0001384101-24-000075 · wk-form4_1717533745.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,971 F1 · kind: The reporting person is reporting the withholding of 381, 362, and 344 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 750, 714, and 677 Restricted Stock Units granted on February 22, 2022, August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:41 UTC |
Bhanji MunaDirector
|
SaleCommon Stock | 1,539 | $21.00 | $32,319.00 |
DisclosureSEC source: 0001384101-24-000069 · wk-form4_1717101697.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,975 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:17 UTC |
EASTHAM KARINDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $13.19 Strike: $13.19 | $131,900.00 |
DisclosureSEC source: 0001384101-24-000047 · wk-form4_1712089048.xml · derivative · entry 3 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 18, 2022. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:17 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 10,000 | $21.65 | $216,528.00 |
DisclosureSEC source: 0001384101-24-000047 · wk-form4_1712089048.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,125 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 18, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $21.45 to $22.09. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:17 UTC |
EASTHAM KARINDirector
|
Exercise / conversionCommon Stock | 10,000 | $13.19 | $131,900.00 |
DisclosureSEC source: 0001384101-24-000047 · wk-form4_1712089048.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 18, 2022. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:50 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 2,189 | $21.10 | $46,187.90 |
DisclosureSEC source: 0001384101-24-000045 · wk-form4_1710881393.xml · nonDerivative · entry 2 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,702 F2 · kind: The reporting person is reporting the withholding of 2,189 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 4,189 Performance Stock Units vested on March 15, 2024 and does not represent a sale by the reporting person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:50 UTC |
Chambers RebeccaChief Financial Officer
|
GrantCommon Stock | 4,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000045 · wk-form4_1710881393.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,891 F1 · kind: Represents the acquisition of restricted stock units ("RSUs") earned by the Reporting Person upon the achievement of performance goals for the one-year period ended December 31, 2023, as reflected in the financial statements and certified by the Compensation Committee of the Board of Directors on March 15, 2024. The RSUs vested March 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:49 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,971 | $21.10 | $125,988.10 |
DisclosureSEC source: 0001384101-24-000044 · wk-form4_1710881378.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,740 F2 · kind: The reporting person is reporting the withholding of 5,971 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 11,780 Performance Stock Units vested on March 15, 2024 and does not represent a sale by the reporting person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:49 UTC |
Stapley MarcDirector · Chief Executive Officer
|
GrantCommon Stock | 11,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000044 · wk-form4_1710881378.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,711 F1 · kind: Represents the acquisition of restricted stock units ("RSUs") earned by the Reporting Person upon the achievement of performance goals for the one-year period ended December 31, 2023, as reflected in the financial statements and certified by the Compensation Committee of the Board of Directors on March 15, 2024. The RSUs vested March 15, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:37 UTC |
McGuire AnnieSVP, General Counsel
|
GrantCommon Stock | 49,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000039 · wk-form4_1709933817.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,325 F1 · kind: Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:37 UTC |
Stapley MarcDirector · Chief Executive Officer
|
GrantCommon Stock | 114,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000041 · wk-form4_1709933854.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,931 F1 · kind: Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:37 UTC |
Leite JohnChief Commercial Officer-CLIA
|
GrantCommon Stock | 49,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000040 · wk-form4_1709933830.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,559 F1 · kind: Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:36 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
GrantCommon Stock | 23,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000038 · wk-form4_1709933802.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,058 F1 · kind: Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:36 UTC |
Chambers RebeccaChief Financial Officer
|
GrantCommon Stock | 59,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000037 · wk-form4_1709933786.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,573 F1 · kind: Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:36 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
GrantCommon Stock | 39,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000036 · wk-form4_1709933775.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,086 F1 · kind: Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:29 UTC |
McGuire AnnieSVP, General Counsel
|
Tax withholdingCommon Stock | 4,347 | $24.00 | $104,328.00 |
DisclosureSEC source: 0001384101-24-000029 · wk-form4_1709677754.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,445 F1 · kind: The reporting person is reporting the withholding of 800, 500 and 3,047 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,429, 892 and 5,853 Restricted Stock Units granted on February 28, 2022, August 5, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:29 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 2,337 | $24.00 | $56,088.00 |
DisclosureSEC source: 0001384101-24-000028 · wk-form4_1709677724.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,116 F1 · kind: The reporting person is reporting the withholding of 420, 400, and 1,517 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 750, 713, and 2,709 Restricted Stock Units granted on February 22, 2022, August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 433 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:27 UTC |
Leite JohnChief Commercial Officer-CLIA
|
Tax withholdingCommon Stock | 3,008 | $24.00 | $72,192.00 |
DisclosureSEC source: 0001384101-24-000025 · wk-form4_1709677656.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,679 F1 · kind: The reporting person is reporting the withholding of 900 and 2,108 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,606 and 3,941 Restricted Stock Units, respectively, granted on September 1, 2022 and March 6, 2023 respectively, and does not represent a sale by the reporting person. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:28 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 6,112 | $24.00 | $146,688.00 |
DisclosureSEC source: 0001384101-24-000026 · wk-form4_1709677679.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,717 F1 · kind: The reporting person is reporting the withholding of 1,190, 726, 900 and 3,296 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,296, 1,784 and 6,503 Restricted Stock Units granted on July 19, 2021, March 3, 2022 , August 5, 2022, and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:27 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 13,286 | $24.00 | $318,864.00 |
DisclosureSEC source: 0001384101-24-000024 · wk-form4_1709677638.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,207 F1 · kind: The reporting person is reporting the withholding of 1,613, 1,784 and 9,889 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925, 3,534 and 19,511 Restricted Stock Units granted on June 1, 2021, March 3, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 611 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:28 UTC |
JONES EVAN/ FADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $13.19 Strike: $13.19 | $131,900.00 |
DisclosureSEC source: 0001384101-24-000027 · wk-form4_1709677710.xml · derivative · entry 4 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:28 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 10,000 | $24.36 | $243,599.00 |
DisclosureSEC source: 0001384101-24-000027 · wk-form4_1709677710.xml · nonDerivative · entry 2 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,601 F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.24 to $24.45. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:28 UTC |
JONES EVAN/ FADirector
|
Exercise / conversionCommon Stock | 10,000 | $13.19 | $131,900.00 |
DisclosureSEC source: 0001384101-24-000027 · wk-form4_1709677710.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:45 UTC |
McGuire AnnieSVP, General Counsel
|
Tax withholdingCommon Stock | 803 | $26.54 | $21,311.62 |
DisclosureSEC source: 0001384101-23-000173 · wk-form4_1701812731.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,792 F1 · kind: The reporting person is reporting the withholding of 494 and 309 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,428 and 891 Restricted Stock Units granted on February 28, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:45 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 507 | $26.54 | $13,455.78 |
DisclosureSEC source: 0001384101-23-000172 · wk-form4_1701812717.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,020 F1 · kind: The reporting person is reporting the withholding of 260 and 247 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 750 and 713 Restricted Stock Units granted on February 22, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:45 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 3,203 | $26.54 | $85,007.62 |
DisclosureSEC source: 0001384101-23-000171 · wk-form4_1701812704.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,882 F1 · kind: The reporting person is reporting the withholding of 1,451 and 1,752 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926 and 3,533 Restricted Stock Units granted on June 1, 2021 and March 3, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:45 UTC |
Leite JohnChief Commercial Officer-CLIA
|
Tax withholdingCommon Stock | 556 | $26.54 | $14,756.24 |
DisclosureSEC source: 0001384101-23-000170 · wk-form4_1701812692.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,687 F1 · kind: The reporting person is reporting the withholding of 556 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,606, Restricted Stock Units granted on September 1, 2022 and does not represent a sale by the reporting person. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:44 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 1,800 | $26.54 | $47,772.00 |
DisclosureSEC source: 0001384101-23-000169 · wk-form4_1701812679.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,829 F1 · kind: The reporting person is reporting the withholding of 735, 448 and 617 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,295 and 1,783 Restricted Stock Units granted on July 19, 2021, March 3, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:35 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
GrantStock Option (right to buy) · Derivative | 85,858 | $0.00 Strike: $21.96 | $0.00 |
DisclosureSEC source: 0001384101-23-000155 · wk-form4_1696451687.xml · derivative · entry 2 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,858 Underlying: Common Stock · 85,858 shares Expires 2033-10-02 F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on October 2, 2024, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:35 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
GrantCommon Stock | 53,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-23-000155 · wk-form4_1696451687.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,182 F1 · acquired: Restricted stock units awarded on October 2, 2023 vest 25% on December 2, 2024 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 20:35 UTC |
McGuire AnnieSVP, General Counsel
|
Tax withholdingCommon Stock | 1,729 | $26.70 | $46,164.30 |
DisclosureSEC source: 0001384101-23-000150 · wk-form4_1694032529.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,595 F1 · kind: The reporting person is reporting the withholding of 495 and 1,234 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,429 and 3,568 Restricted Stock Units granted on February 28, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 20:33 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 3,204 | $26.70 | $85,546.80 |
DisclosureSEC source: 0001384101-23-000149 · wk-form4_1694032399.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,085 F1 · kind: The reporting person is reporting the withholding of 1,451 and 1,753 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925 and 3,534 Restricted Stock Units granted on June 1, 2021 and March 3, 2022, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 593 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 20:31 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,247 | $26.70 | $33,294.90 |
DisclosureSEC source: 0001384101-23-000148 · wk-form4_1694032286.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,527 F1 · kind: The reporting person is reporting the withholding of 260 and 987 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 750 and 2,854 Restricted Stock Units granted on February 22, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 420 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 20:30 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 3,652 | $26.70 | $97,508.40 |
DisclosureSEC source: 0001384101-23-000147 · wk-form4_1694032228.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,629 F1 · kind: The reporting person is reporting the withholding of 735, 449 and 2,468 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125, 1,296 and 7,135 Restricted Stock Units granted on July 19, 2021, March 3, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 527 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 20:29 UTC |
Leite JohnChief Commercial Officer-CLIA
|
Tax withholdingCommon Stock | 2,222 | $26.70 | $59,327.40 |
DisclosureSEC source: 0001384101-23-000146 · wk-form4_1694032160.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,243 F1 · kind: The reporting person is reporting the withholding of 2,222 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 6,424 Restricted Stock Units granted on September 1, 2022 and does not represent a sale by the reporting person. Read SEC document |
| July 19, 2023 Filed Jul 24, 2023 21:06 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 3,090 | $30.17 | $93,232.41 |
DisclosureSEC source: 0001384101-23-000134 · wk-form4_1690232803.xml · nonDerivative · entry 2 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by jVen Capital, LLC Disclosed balance after: 35,173 F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.01 to $30.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. F3 · acquired: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 12, 2022. F5 · ownership.nature: The Reporting Person is the sole managing member of jVen Capital, LLC. Read SEC document |
| July 19, 2023 Filed Jul 24, 2023 21:06 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 838 | $30.14 | $25,257.15 |
DisclosureSEC source: 0001384101-23-000134 · wk-form4_1690232803.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,601 F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.01 to $30.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. F1 · acquired: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.